1. Home
  2. CREX vs PDSB Comparison

CREX vs PDSB Comparison

Compare CREX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.11

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.71

Market Cap

40.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREX
PDSB
Founded
N/A
2005
Country
United States
United States
Employees
N/A
10
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
40.0M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
CREX
PDSB
Price
$3.11
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
27.1K
248.7K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
28.16
EPS
N/A
N/A
Revenue
$18,437,000.00
N/A
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$2.19
$0.51
52 Week High
$4.42
$1.55

Technical Indicators

Market Signals
Indicator
CREX
PDSB
Relative Strength Index (RSI) 34.98 40.72
Support Level $2.67 $0.70
Resistance Level $3.09 $0.76
Average True Range (ATR) 0.16 0.04
MACD -0.02 0.01
Stochastic Oscillator 1.49 47.87

Price Performance

Historical Comparison
CREX
PDSB

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: